VEGFA and colorectal carcinoma: For instance, KRAS-A and VEGFA 165b variant are superior predictors of overall survival whereas CD44v6, CEACAM1-Short isoform, and Δ133p53β variant are poor predictors of overall survival among patients with CRC [59, 85, 88, 90, 97, 98, 104–106].